Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Quince Therapeutics has raised $115.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Quince Therapeutics's investors include Sequoia Capital, Balyasny Asset Management, Cormorant Asset Management, Verily, Pfizer.
Quince Therapeutics is headquartered in South San Francisco, United States.
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Quince Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quince Therapeutics — Funding & Investors." VCBacked, May 18, 2026, https://www.vcbacked.co/company/quince-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Quince Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/quince-therapeutics
{{cite web |title=Quince Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quince-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated